Pages
- Losing a Loved One to Mesothelioma
- Information for Mesothelioma Caregivers
- TREATMENT
- Treatment Overview
- Mesothelioma Survivor Stories
- GET INVOLVED/EVENTS
- Peer-to-Peer Support Program for mesothelioma patients and families
- ABOUT US
- Contact Us
- Resources and Collaborations
- Brian Lepacek, MDiv, CAE, Executive Director
- Accreditations
- 990 Forms and Audits
- Annual Reports
- Community Advisory Board
- Science Advisory Board
- Board of Directors
- Bill Ziegler, Board of Directors
- Loc Ta, Board of Directors
- Daniel Sterman, MD, Board of Directors
- R. Taylor Ripley, MD, Board of Directors
- Aaron Mansfield, MD, Board of Directors
- Jason Foster, MD, Board of Directors
- Darciena Christel, Chair, Board of Directors
- Keith Cengel, MD, PhD, Board of Directors
- Cheryl Bruner, Esq., Board of Directors
- Jessica Blackford-Cleeton, Board of Directors
- Marjorie G. Zauderer, MD, Immediate Past Chair, Board of Directors
- Melina Marmarelis, MD, MSCE Board of Directors
- Fabian Johnston, MD, MHS, Board of Directors
- Adam Bograd, MD, Board of Directors
- Carolyn Shields, MBA, Development Director
- Melissa Gerard, Communications Manager
- Job Opportunities
- Teresa Skidmore, Administrative Program Coordinator
- Melissa David
- Julie White, RN, BSN, OCN, Director of Patient Services
- Mission Statement
- Mesothelioma Support Groups for Patients, Caregivers, Bereaved
- Mesothelioma Research Funding
- DONATE
- Financial Assistance for Mesothelioma Patients
- LEARN
- MesoTV
- Meet the Mesothelioma Experts Broadcast Series
- Vaccines: Can we manipulate the immune system to prevent recurrence following a PD/EPP?
- Recent Advances in Mesothelioma Gene Therapy
- Mesothelin: A New Target for Immunotherapy
- NGR-hTTNF: A New Multi-Center Drug Trial for Pleural Mesothelioma
- Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
- Designing Clinical Trials for Mesothelioma
- New Frontiers in Surgery for Mesothelioma
- Focused Discussion of a New Clinical Trial: GL-ONC1
- Defactinib, a New Investigational Agent for Mesothelioma
- Mesothelioma Clinical Trial Using PD-L1 Inhibitors
- CRS-207: Using a Modified Listeria Virus to Fight Mesothelioma
- Focus on Mesothelioma Centers of Excellence: Hedy Lee Kindler, MD, University of Chicago Medicine
- Focus on Centers of Excellence: Penn Medicine with Dr. Evan Alley and Dr. Charles Simone
- 2015 Grant Recipient Interviews
- Current Trends in Mesothelioma Surgery and Research: The International Mesothelioma Program at Brigham and Women’s Hospital
- Meet Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center
- Targeting the Immune System with Daniel H. Sterman, MD
- An Interview with William A. Franco and Julie P. Pawelczyk of The Conafay Group
- An Interview with Aduro Biotech
- Front-line clinical trial for non-epithelioid mesothelioma
- Breath test for early detection of mesothelioma is in the works
- Phase 3 Study of TR002, an adenovirus-mediated interferon alfa 2b
- Mesothelioma Program at Veterans Affairs Medical Center in Houston, Texas
- Immunotherapy for mesothelioma: what’s next?
- Pre-Operative Immunotherapy Clinical Trial with Dr. Patrick Forde of Johns Hopkins
- Discussing the Tumor Treating Fields device for mesothelioma with Dr. Zachary Horne
- Meet the Mesothelioma Experts: Legal Edition with Joe Belluck, of Belluck & Fox, LLP
- Meet the Mesothelioma Experts: Legal Edition w/ Maune Raichle Hartley French & Mudd, LLC (MRHFM) law firm
- Present and Future of Immunotherapy Treatment for Mesothelioma
- Meet the Mesothelioma Experts: YOUR legal questions answered
- Meso Foundation Blog and News
- Patient Support and Resources
- UNDERSTANDING MESOTHELIOMA
- Calendar
- Michigan State University Mesothelioma Caregiver Experience
- Mesothelioma Applied Research Foundation
- Ibiayi Dagogo-Jack, MD, Board of Directors
- Research Projects Funded by the Meso Foundation
- Research Projects Funded by the Meso Foundation
- Fundraising Events Calendar